Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer, Glaxo Find Steps Difficult Toward Better Margins In Consumer Product Space

This article was originally published in The Tan Sheet

Executive Summary

Glaxo and Bayer report second-quarter growth in consumer segment sales driven largely by the new parts of the businesses. GSK’s earnings report is its first since taking the helm of a consumer product JV with Novartis AG; Bayer’s is its second with Merck & Co.’s former consumer products brands in its lineup.

Advertisement

Related Content

Nonprescription Nasonex Gains UK Regulator’s Support
Lonely At The Top? Not In OTC Sector As Bayer, GSK/Novartis Challenge J&J

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS107806

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel